INPP5D and Alzheimer disease: Selective agonists and antagonists have been developed for INPP5D64–68 but the biology of INPP5D in the AD brain is complex and it is not immediately apparent whether INPP5D activity should be enhanced or inhibited for therapeutic benefit.